About Millenia
Millenia Hope is committed to improving the quality of life through cures for global diseases. We apply novel approaches, based on natural sourced products, initially focusing on malaria and AIDS.
ABOUT MILLENIA
CLINICAL STUDIES
KEY MANAGEMENT PERSONNEL
BOARD OF DIRECTORS
SCIENTIFIC ADVISORY BOARD
SALES AUTHORIZATION

About Millenia's Sales Authorizations

Millenia Hope has received authorization from 18 countries in Africa and l in the Carribean to sell Malarex in their countries and has expanded its distribution network in order to facilitate the distribution of medications to reach the neediest regions of the world.

In 2005, the Company launched Malarex commercially in Africa by realizing its first two sales, in Guinea Conakry and Mali.


Sales Authorizations received by Millenia Hope until today

Congo Brazzaville, Visa #0710106-215-VC August 10, 2001
République de Guinée (Conakry), Visa #253
January 16, 2002
Togo, Visa #0266
August 12, 2004
Burundi, Visa #1368/32.5
June 18, 2003
République Centre Afrique, Visa #1839 October 4, 2002
République du Tchad, Visa #060 February 26, 2004
République Démocratique Du Congo, Visa# J107.01/06/215/VC April 12, 2004
République Dominicaine, Visa # SAP 086 February 6, 2004
Cameroun, Visa #901035 June 23, 2004
République du Mali, Visa #04098 23 juin 2004
République de la Guinée Équatorial, Visa #04-161-150 October 20, 2004
République du Ghana, Visa # FDB/HD.04-12106 January 19, 2005
République du Niger, Visa #00101 January 26, 2004
Mauritanie, Visa 259013505  

 

 
Severely affected regions
 
Less affected regions
 
Unaffected regions